Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Combigene AB

COMBI
Current price
2.66 SEK +0.12 SEK (+4.72%)
Last closed 2.66 SEK
ISIN SE0016101935
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 41 285 805 SEK
Yield for 12 month -3.97 %
1Y
3Y
5Y
10Y
15Y
COMBI
21.11.2021 - 28.11.2021

CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two candidates for severe chronic pain conditions, which are in preclinical studies include COZY01, a peptide treatment; and COZY02, a gene therapy treatment. It is also developing CG01, an adeno-associated virus-based gene therapy targeting epileptic seizures. The company has a collaboration agreement with Danish company Zyneyro to develop a treatment for chronic pain conditions. CombiGene AB (publ) was incorporated in 1990 and is based in Lidingö, Sweden. Address: Agavagen 52A, Lidingö, Sweden, 181 55

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22.58 SEK

P/E ratio

Dividend Yield

Current Year

+5 557 365 SEK

Last Year

+26 763 667 SEK

Current Quarter

Last Quarter

+326 783 SEK

Current Year

-38 876 521 SEK

Last Year

-19 246 798 SEK

Current Quarter

-694 676 SEK

Last Quarter

-15 272 742 SEK

Key Figures COMBI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -36 834 420 SEK
Operating Margin TTM -1819.23 %
PE Ratio
Return On Assets TTM -19.5 %
PEG Ratio
Return On Equity TTM -32.33 %
Wall Street Target Price 22.58 SEK
Revenue TTM 4 304 365 SEK
Book Value 4.79 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -87 %
Dividend Yield
Gross Profit TTM 9 198 126 SEK
Earnings per share -1.84 SEK
Diluted Eps TTM -1.84 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics COMBI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History COMBI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 07.06.2021
Dividend Date

Stock Valuation COMBI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.0421
Price Sales TTM 9.5916
Enterprise Value EBITDA 0.8572
Price Book MRQ 0.4349

Financials COMBI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators COMBI

For 52 weeks

1.27 SEK 4.31 SEK
50 Day MA 2.49 SEK
Shares Short Prior Month
200 Day MA 3.11 SEK
Short Ratio
Shares Short
Short Percent